Neoadjuvant chemotherapy in cervical carcinoma during pregnancy: Case report.
- Author:
Se Hee MUN
1
;
Hee Sug RYU
;
Hye Jin CHANG
;
Ho Yeon KIM
;
Ki Hong CHANG
;
Jung Pil LEE
Author Information
1. Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea. hsryu@ajou.ac.kr
- Publication Type:Case Report
- Keywords:
Pregnancy;
Cervix cancer;
Neoadjuvant chemotherapy
- MeSH:
Biopsy;
Brain;
Cesarean Section;
Drug Therapy*;
Female;
Fetal Viability;
Fetus;
Follow-Up Studies;
Humans;
Hysterectomy;
Lymph Node Excision;
Lymph Nodes;
Mothers;
Parturition;
Pregnancy*;
Uterine Cervical Neoplasms
- From:Korean Journal of Gynecologic Oncology
2005;16(3):268-272
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
When the cervical cancer is diagnosed in early stage during pregnancy, the treatment can be postponed for fetal viability. This case presents a patient diagnosed as cervical cancer stage Ib1 during her pregnancy. The patient had 2 cycles of neoadjuvant chemotherapy (Paclitaxel-cisplatin) formerly and cesarean section was done at 33rd weeks of intrauterine pregnancy, then radical abdominal hysterectomy with bilateral pelvic lymph node dissection and paraaortic lymph node biopsy was immediately performed right after the delivery. For the baby born, there was neither complication nor congenital anomaly but mild bilateral ventriculomegaly seen on brain CT taken on 3 days after birth. This case offers a better chance for both mother and fetus while conserving fetal viability and managing the early cervical cancer during pregnancy through close follow up.
